The transplant hepatologist, or liver specialist, monitors all non-surgical aspects of patient care. This includes performing examinations, assessing test results and adjusting medication as needed.
Kenneth D. Rothstein, MD
Chief, Division of Gastroenterology and Hematology
Associate Professor of Medicine, Drexel University College of Medicine
Dr. Rothstein is renowned in the field of hepatology, with over 20 years of experience. Dr. Rothstein is highly experienced in treating complications of cirrhosis, including ascites, variceal bleeding, hepatic encephalopathy and hepatocellular carcinoma. He is also an expert on new treatments for Hepatitis B and C, and on long-term healthcare following transplantation. Dr. Rothstein is certified by the American Board of Internal Medicine in Transplant Hepatology, Gastroenterology and Internal Medicine. He was selected as a “Top Doc” in 2016 by Philadelphia Magazine.
Santiago J. Munoz, MD, FACP, FACG
Chief, Hepatology and Liver Failure Unit; Medical Director, Liver Transplant
Distinguished Professor, Drexel University College of Medicine
Dr. Munoz has been practicing hepatology in the Philadelphia area for nearly three decades. He specializes in the diagnosis and treatment of benign and malignant liver diseases and has a focus on liver failure patients. Before coming to Hahnemann, Dr. Munoz developed and led several liver transplant programs in the Philadelphia area. In addition to being certified by the American Board of Internal Medicine, Dr. Munoz is certified by the Subspecialty Board of Gastroenterology and Transplant Hepatology. He is also frequently named among Philadelphia magazine’s annual list of Top Doctors.
Vishal Patel, MD
Associate Medical Director, Liver Transplant Program
Assistant Professor, Drexel University College of Medicine
Dr. Patel specializes in cirrhosis and complications of portal hypertension, care of pre and post liver transplant patients, hepatocellular carcinoma (HCC), viral and autoimmune hepatitis, obesity, and fatty liver disease. In addition to being certified by the American Board of Internal Medicine, Dr. Patel is also board certified by the American Board of Obesity Medicine. This certification arose from his interest in fatty liver disease which is largely due to the metabolic syndrome and obesity.
Andrés Riera, MD
Assistant Professor of Medicine, Drexel University College of Medicine
Dr. Riera’s focus is on the treatment of advanced liver disease and its complications, with a particular interest in hepatocellular carcinoma. He has participated in numerous scientific research studies specific to advancements in treating end stage liver disease. Dr. Riera completed his medical degree at the J.M. Vargas School of Medicine at the Central University of Venezuela and his residency in Internal Medicine and fellowship in Hepatology at Hahnemann University Hospital, Drexel University College of Medicine. He is certified by the American Board of Internal Medicine and fluent in Spanish and English.